How Happel was paid
$3.2M in total for 2025, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.
Named executive officers
| Executive | Salary | Stock | Options | Incentive | Other | Total |
|---|---|---|---|---|---|---|
| David HappelPresident and Chief Executive Officer | $630,000 | $546,360 | $1,749,751 | $294,525 | $19,358 | $3,239,994 |
| Elizabeth Rozek, Esq.Chief Legal and Administrative Officer | $483,333 | $235,137 | $591,668 | $170,000 | $16,564 | $1,496,702 |
| Eduardo Bruno Martins, M.D., D.Phil.Former Chief Medical Officer | $500,000 | $160,140 | $511,580 | $170,000 | $19,121 | $1,360,841 |
What changed and why
- $3.2MDavid Happel received total compensation of $3,239,994 in fiscal 2025, an increase from $906,164 in 2024.
- $630KBase salary for the CEO increased to $630,000 in 2025 from $582,000 in 2024.
- 85%The 2025 corporate goals were achieved at 85%, resulting in a bonus payout of $294,525 for the CEO.
- Named executive officers were granted both stock options and restricted stock units in February 2025.
About this page
Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.